We were able to include: (a) 42 DEPs, namely, angiotensin-converting enzyme 2 (ACE2), advanced glycosylation end-product specific receptor (AGER), agrin (AGRN), ALB, CCL2, CCL4, CCL11, CD3D, CD8A, CD19, CD38, CD69, HLA-DR, creatine phosphokinase (CKM), CLDN5, CSF2, CRP, CTNNB1, DKK1, ELANE, GPX1, hemoglobin A1 (HbA1), HP, HMGB1, interleukin-1 (IL-1), interleukin-1 (IL-1), IL-1RN (IL-1RA), IL-6, IL-10, LYZ, NFKB1 (NF-B), NOS2, OCLN, opioid receptor Kappa 1 (OPRK1), opioid receptor Mu 1 (OPRM1), proopiomelanocortin (POMC) as precursor of -endorphins, PTGS2, RSPO1, TLR4, TNF (TNF-), TNFRSF1A (TNFR60), and TNFRSF1B (TNFR80) and (b) 12 metabolic Kyoto Encyclopedia of Genes and Genomes (KEGG) 1 pathways, namely, C01290 (lactosylceramide), C02470 (xanthurenate), C10164 (picolinic acid), C03227 [3-OH-L-kynurenine (3OHK)], C11378 (coenzyme Q10), C00038 (zinc), C00070 (copper), C06428 [eicosapentaenoic acid (EPA)], C00027 [hydrogen peroxides (H 2 O 2 )], C19440 [malondialdehyde (MDA)], C004555 (DHEA), and C05926 (neopterin)

Step four
Amylin modulates a ventral tegmental areatomedial prefrontal cortex circuit to suppress food intake and impulsive food-directed behavior
Low-utilizing (LU) members are those who the state defined as utilizing three or fewer services per year and have little to no connectivity with their PCP or care manager
Wegovy is specifically approved for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition